Diagnostic performance of (68)Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with (18)FEC PET/CT

BACKGROUND: Radiolabeled prostate-specific membrane antigen (PSMA) has proven to be a highly accurate method to detect recurrence and metastases of prostate cancer, but only sparse data is available about its performance in the diagnosis of clinically significant primary prostate cancer. METHODS: We...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Hoffmann, Manuela A., Miederer, Matthias, Wieler, Helmut J., Ruf, Christian, Jakobs, Frank M., Schreckenberger, Mathias
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762306/
https://ncbi.nlm.nih.gov/pubmed/29340038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22441
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares